NYSE:ALUR Allurion Technologies (ALUR) Stock Price, News & Analysis → America’s worst nightmare? (From Porter & Company) (Ad) Free alur Stock Alerts $1.84 -0.10 (-4.90%) (As of 10:57 AM ET) Add Compare Share Share Today's Range$1.82▼$2.0550-Day Range$1.67▼$3.0852-Week Range$1.56▼$9.00Volume46,207 shsAverage Volume700,367 shsMarket Capitalization$88.28 millionP/E RatioN/ADividend YieldN/APrice Target$5.00 Stock AnalysisStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesOptions ChainOwnershipSEC FilingsShort InterestSocial Media Get Allurion Technologies alerts: Email Address Allurion Technologies MarketRank™ Stock AnalysisAnalyst RatingBuy3.00 Rating ScoreUpside/Downside144.0% Upside$5.00 Price TargetShort InterestHealthy1.45% of Float Sold ShortDividend StrengthN/ASustainabilityN/ANews Sentiment0.33Based on 4 Articles This WeekInsider TradingN/AProj. Earnings GrowthGrowingFrom ($0.87) to ($0.48) Per ShareSee Full Details Hide Full Details Overall MarketRank™New Rank-Based ScoringMarketRank™ is calculated by averaging available category scores (with extra weight given to analysis and valuation), then ranking the company's weighted average against that of other companies.2.56 out of 5 starsMedical Sector1422nd out of 2,771 stocksSurgical & Medical Instruments Industry178th out of 300 stocks 3.5 Analyst's Opinion Consensus RatingAllurion Technologies has received a consensus rating of Buy. The company's average rating score is 3.00, and is based on 2 buy ratings, no hold ratings, and no sell ratings.Amount of Analyst CoverageAllurion Technologies has only been the subject of 1 research reports in the past 90 days.Read more about Allurion Technologies' stock forecast and price target. Previous Next 5.0 Short Interest Percentage of Shares Shorted1.45% of the float of Allurion Technologies has been sold short.Short Interest Ratio / Days to CoverAllurion Technologies has a short interest ratio ("days to cover") of 0.5, which is generally considered an acceptable ratio of short interest to trading volume.Change versus previous monthShort interest in Allurion Technologies has recently decreased by 16.36%, indicating that investor sentiment is improving significantly. Previous Next 0.0 Dividend Strength Dividend YieldAllurion Technologies does not currently pay a dividend.Dividend GrowthAllurion Technologies does not have a long track record of dividend growth. Previous Next N/A Sustainability and ESG Overall ESG (Environmental, Social, and Governance) ScoreThere is no current Upright™ data available for ALUR. Previous Next 1.9 News and Social Media Coverage News SentimentAllurion Technologies has a news sentiment score of 0.33. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a lower news sentiment than the 0.57 average news sentiment score of Medical companies.News Coverage This WeekMarketBeat has tracked 4 news articles for Allurion Technologies this week, compared to 1 article on an average week. Previous Next 0.8 Company Ownership Insider Buying vs. Insider SellingIn the past three months, Allurion Technologies insiders have not sold or bought any company stock.Percentage Held by Insiders20.00% of the stock of Allurion Technologies is held by insiders. A high percentage of insider ownership can be a sign of company health.Percentage Held by InstitutionsOnly 21.39% of the stock of Allurion Technologies is held by institutions.Read more about Allurion Technologies' insider trading history. Previous Next 0.6 Earnings and Valuation Earnings GrowthEarnings for Allurion Technologies are expected to grow in the coming year, from ($0.87) to ($0.48) per share.Read more about Allurion Technologies' valuation and earnings. Previous Next See Top Rated MarketRank™ Stocks Here Ad InvestorPlaceElon Musk’s Next Move Will Disrupt AI ForeverA revolutionary venture that is set to get rolled out by May 16. One well-connected Silicon Valley VC has uncovered a way for anybody to claim a stake in "Elon Musk's AI 2.0" with as little as $100.Get all the information here. About Allurion Technologies Stock (NYSE:ALUR)Allurion Technologies Inc. focuses on ending obesity with a weight loss platform to treat people who are overweight. Its platform, the Allurion Program, features swallowable and procedure-less intragastric balloon for weight loss (the Allurion Balloon), as well as offers access to AI-powered remote patient monitoring tools, a proprietary behavior change program, secure messaging, and video telehealth that are delivered by the Allurion Virtual Care Suite. Allurion Technologies Inc. is headquartered in Natick, Massachusetts.Read More ALUR Stock Price History View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart ALUR Stock News HeadlinesMay 14 at 8:00 AM | businesswire.comAllurion Reports First Quarter 2024 Financial Results and Provides Business UpdateMay 12 at 1:56 AM | americanbankingnews.comAllurion Technologies (ALUR) to Release Quarterly Earnings on TuesdayMay 4, 2024 | markets.businessinsider.comAllurion Technologies Inc Registered Shs hosts conference call for investorsMay 2, 2024 | businesswire.comAllurion Announces Three Scientific Presentations at IFSO-European Chapter 2024, Including First-Ever 3-Year Weight Maintenance SurveyApril 30, 2024 | finance.yahoo.comAllurion Announces Preliminary First Quarter 2024 ResultsApril 18, 2024 | investing.comAllurion secures $48 million in convertible note financingApril 17, 2024 | finance.yahoo.comAllurion Closes $48 Million Convertible Senior Secured Note Financing with RTW InvestmentsApril 17, 2024 | businesswire.comAllurion Closes $48 Million Convertible Senior Secured Note Financing with RTW InvestmentsApril 4, 2024 | marketwatch.comAllurion Technologies Shares Surge 72% After Expanding Virtual Care to U.S.April 4, 2024 | investorplace.comWhy Is Allurion (ALUR) Stock Up 65% Today?April 4, 2024 | msn.comARCA biopharma, Achilles Therapeutics, MSP Recovery among healthcare moversApril 4, 2024 | benzinga.comNasdaq Surges 1%; ConAgra Brands Posts Upbeat EarningsApril 4, 2024 | msn.comAllurion stock soars 85% on weight-loss product launchApril 4, 2024 | businesswire.comAllurion Expands Virtual Care Suite to the United StatesMarch 30, 2024 | uk.finance.yahoo.comAllurion Technologies Full Year 2023 Earnings: US$2.31 loss per share (vs US$1.51 loss in FY 2022)March 23, 2024 | seekingalpha.comAllurion Technologies Inc. (ALUR) Q4 2023 Earnings Call TranscriptMarch 22, 2024 | msn.comAllurion Technologies Inc. (NYSE:ALUR) Q4 2023 Earnings Call TranscriptMarch 21, 2024 | msn.comAllurion Technologies reports mixed Q4 results; reaffirms FY24 outlookMarch 21, 2024 | investorplace.comALUR Stock Earnings: Allurion Technologies Beats EPS, Beats Revenue for Q4 2023March 21, 2024 | finance.yahoo.comAllurion Reports Fourth Quarter and Full Year 2023 Financial Results and Reiterates 2024 GuidanceMarch 13, 2024 | finance.yahoo.comAllurion to Participate in the Oppenheimer 34th Annual Healthcare MedTech & Services ConferenceMarch 12, 2024 | finance.yahoo.comMilena Alberti-Perez Joins Allurion Board of Directors as Audit Committee ChairMarch 4, 2024 | finance.yahoo.comAllurion to Report Fourth Quarter 2023 Financial Results on March 21, 2024March 3, 2024 | ca.finance.yahoo.comALUR Apr 2024 2.500 callFebruary 20, 2024 | finance.yahoo.comAllurion to Participate in Cowen’s 44th Annual Health Care ConferenceSee More Headlines Receive ALUR Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Allurion Technologies and its competitors with MarketBeat's FREE daily newsletter. Email Address Company Calendar Last Earnings3/21/2024Today5/14/2024Next Earnings (Confirmed)5/14/2024Fiscal Year End12/31/2024Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNYSE SectorMedical Industry Surgical & medical instruments Sub-IndustryN/A Current SymbolNYSE:ALUR Previous SymbolNYSE:ALUR CUSIPN/A CIK1964979 Webwww.allurion.com Phone508-647-4000FaxN/AEmployees501Year FoundedN/APrice Target and Rating Average Stock Price Target$5.00 High Stock Price Target$5.00 Low Stock Price Target$5.00 Potential Upside/Downside+155.1%Consensus RatingBuy Rating Score (0-4)3.00 Research Coverage2 Analysts Profitability EPS (Most Recent Fiscal Year)N/A Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income$-80,610,000.00 Net MarginsN/A Pretax Margin-150.27% Return on EquityN/A Return on Assets-97.97% Debt Debt-to-Equity RatioN/A Current Ratio0.99 Quick Ratio0.90 Sales & Book Value Annual Sales$53.47 million Price / Sales1.75 Cash FlowN/A Price / Cash FlowN/A Book Value($1.48) per share Price / Book-1.32Miscellaneous Outstanding Shares47,850,000Free Float38,282,000Market Cap$93.79 million OptionableOptionable Beta-0.13 13 Stocks Institutional Investors Won't Stop BuyingWhich stocks are major institutional investors including hedge funds and endowments buying in today's market? Click the link below and we'll send you MarketBeat's list of thirteen stocks that institutional investors are buying up as quickly as they can.Get This Free Report Key ExecutivesDr. Shantanu K. Gaur M.D. (Age 37)Co-Founder, CEO, President & Director Comp: $383.86kDr. Samuel G. Levy (Age 41)Co-Founder Mr. Christopher Geberth (Age 53)CFO & Treasurer Comp: $408.95kDr. Ram Chuttani M.D. (Age 64)MD, Chief Medical Officer & Founding Partner Mr. Brendan Michael Gibbons (Age 48)Chief Legal Officer & Corporate Secretary Matt WrightVice President of PeopleMs. Joyce JohnsonSenior Vice President of RA & QAMore ExecutivesKey CompetitorsKORU Medical SystemsNASDAQ:KRMDBlueRiver AcquisitionNYSE:BLUABrainsWayNASDAQ:BWAYTELA BioNASDAQ:TELANeuroneticsNASDAQ:STIMView All Competitors ALUR Stock Analysis - Frequently Asked Questions Should I buy or sell Allurion Technologies stock right now? 2 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Allurion Technologies in the last twelve months. There are currently 2 buy ratings for the stock. The consensus among Wall Street analysts is that investors should "buy" ALUR shares. View ALUR analyst ratings or view top-rated stocks. What is Allurion Technologies' stock price target for 2024? 2 brokerages have issued 12 month price objectives for Allurion Technologies' shares. Their ALUR share price targets range from $5.00 to $5.00. On average, they expect the company's share price to reach $5.00 in the next year. This suggests a possible upside of 144.0% from the stock's current price. View analysts price targets for ALUR or view top-rated stocks among Wall Street analysts. How have ALUR shares performed in 2024? Allurion Technologies' stock was trading at $3.74 on January 1st, 2024. Since then, ALUR shares have decreased by 45.2% and is now trading at $2.0495. View the best growth stocks for 2024 here. Are investors shorting Allurion Technologies? Allurion Technologies saw a decline in short interest during the month of April. As of April 30th, there was short interest totaling 526,700 shares, a decline of 16.4% from the April 15th total of 629,700 shares. Based on an average trading volume of 991,000 shares, the short-interest ratio is currently 0.5 days. Approximately 1.5% of the shares of the company are sold short. View Allurion Technologies' Short Interest. When is Allurion Technologies' next earnings date? The company is scheduled to release its next quarterly earnings announcement on Tuesday, May 14th 2024. View our ALUR earnings forecast. How were Allurion Technologies' earnings last quarter? Allurion Technologies Inc. (NYSE:ALUR) released its earnings results on Thursday, March, 21st. The company reported ($0.63) earnings per share (EPS) for the quarter, missing analysts' consensus estimates of ($0.51) by $0.12. The company had revenue of $8.24 million for the quarter, compared to analyst estimates of $8.20 million. What guidance has Allurion Technologies issued on next quarter's earnings? Allurion Technologies issued an update on its first quarter 2024 earnings guidance on Tuesday, April, 30th. The company provided earnings per share guidance of for the period. The company issued revenue guidance of $9.2 million-$9.3 million, compared to the consensus revenue estimate of $9.0 million. Who are Allurion Technologies' major shareholders? Allurion Technologies' stock is owned by a variety of institutional and retail investors. Top institutional shareholders include Concourse Financial Group Securities Inc. (0.00%). How do I buy shares of Allurion Technologies? Shares of ALUR stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Compare Top Brokerages Here. This page (NYSE:ALUR) was last updated on 5/14/2024 by MarketBeat.com Staff From Our PartnersHealthcare Takes A Big Step Forward With The Help Of AIThe Bull ReportRevolutionizing the Green Energy Space and Building Shareholder Value Along the WaySmall Cap SniperDemocrats Push to Replace Dollar With Digital Coin, Control Currency.Monetary GoldThis 1 Biotech Stock has been shocking the marketsHuge AlertsClaim Your Complimentary Bitcoin RewardCrypto Swap ProfitsElon’s New Device is About to Shock the WorldInvestorPlaceCharles Payne Demystifies OptionsUnstoppable ProsperityWhat’s Really Next for America…Porter & Company Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Allurion Technologies Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
